about
Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic CancerStromal Targets for Fluorescent-Guided Oncologic SurgeryPancreatic cancer: yesterday, today and tomorrow.Molecular Imaging of Pancreatic Cancer with Antibodies.Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapiesHippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progressionApplying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsPancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.The need for effective pancreatic cancer detection and management: a biomarker-based strategy.Evolving treatment landscape for early and advanced pancreatic cancer.ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin.Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.Acquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes.Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death.Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861.An overview of polyamine metabolism in pancreatic ductal adenocarcinoma.Experimental models of pancreatic cancer desmoplasia.Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer.Role of TRPC1 channels in pressure-mediated activation of murine pancreatic stellate cells.A modified 384-well-device for versatile use in 3D cancer cell (co-)cultivation and screening for investigations of tumor biology in vitro.Pancreatic cancer survival analysis defines a signature that predicts outcome
P2860
Q26765241-6AF0E9E3-117B-409C-823C-2816CC2F96D0Q26774497-EDFA8658-98A1-48B3-BCE7-C2DE7A088176Q30250026-AD74C3B9-BBE7-46A8-B238-8935E34D8C7BQ30393523-B3749494-EF5F-4095-8406-A2289770896FQ34537580-C98DFA9B-7551-49DF-9516-4F29AD82C6CFQ36515479-BF958E86-C858-487B-B41E-F6D8C2CC8E6DQ36546520-8D0082E0-2D63-4F6A-934C-957942A8D550Q36918125-25B8D683-CCCE-4AEE-B4AA-03A24311B047Q37588378-E9ADDCF6-77A5-444A-B8EC-7E2E0EACBA8DQ38591066-7948996A-7F42-4580-9B28-4E076E597C4BQ38624806-FCCC9D75-2D33-43EB-B3C2-B2228A8A1057Q38727369-1E260996-ABE2-4286-ADF8-919F787921E2Q39577399-FF473940-0A16-41DE-808D-52E189DC2B95Q42351657-993D6F98-CD5D-4D07-A544-EDB8236560D6Q42419195-20929BA0-E774-4BA8-B7C4-A9217E642CD9Q47101471-D4CC3F0B-4D58-417C-AD8F-3C819325AE6AQ48310001-08127843-BF83-4319-86D7-F82AD592A1C2Q49859674-7A48B76F-D195-4669-9D8A-06ADB263954DQ50544084-7BDEAFC4-CCA1-459F-A973-2970BAA1EB35Q51459972-A86DF82C-BD5A-4C72-89A9-D97DE2DF90EFQ52611695-0E3340BE-EC79-4D49-B0EB-CC4DE61213A5Q57136038-1251A0AD-6E0F-4355-A7C3-9B7BCF83D7CB
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pancreatic cancer stromal biology and therapy.
@ast
Pancreatic cancer stromal biology and therapy.
@en
type
label
Pancreatic cancer stromal biology and therapy.
@ast
Pancreatic cancer stromal biology and therapy.
@en
prefLabel
Pancreatic cancer stromal biology and therapy.
@ast
Pancreatic cancer stromal biology and therapy.
@en
P2860
P1433
P1476
Pancreatic cancer stromal biology and therapy.
@en
P2093
Dacheng Xie
Keping Xie
P2860
P304
P356
10.1016/J.GENDIS.2015.01.002
P577
2015-06-01T00:00:00Z